US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

70.38

-1.4046-1.96%

Volume:408

Turnover:28.74K

Market Cap:703.87K

PE:- -

High:70.56

Open:70.46

Low:70.38

Close:71.78

52wk High:85.03

52wk Low:56.03

Shares:10.00K

Float Shares:10.00K

Volume Ratio:1.98

T/O Rate:4.08%

Dividend:2.07

Dividend Rate:2.95%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GSK executives boost holdings via dividend-funded ADS purchases

GSK’s New Phase 3 Ovarian Cancer Trial Puts Mo-Rez in the First-Line Spotlight

Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial?

Simply Wall St.

GSK Completes $10.6 Billion Acquisition of Nuvalent

MT Newswires Live

iX Biopharma Warrants See Strong Insider Take-Up, Funding U.S. Expansion

GSK Executives Acquire Shares Under Routine Reward Plan

UBS Remains a Hold on GlaxoSmithKline (GSK)

GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients

Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS

Guggenheim Remains a Hold on GlaxoSmithKline (GSK)

GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China

Revenue Revision at Frontier Biotech Highlights Channel Pressures as Operating Losses Widen

GSK US President Acquires Notional ADS Under Executive Savings Plan

GSK Adds Philips CEO Roy Jakobs to Board as Independent Director

SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE

Alector Ends GSK Collaboration, Retires Hercules Capital Debt

GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio

GSK Targets Pediatric Vaccine Growth With New Phase 3 Trial Against Merck’s ProQuad

GSK Advances Novel Malaria Drug Into Phase 2A, Signaling Long-Term Global Health Upside

GSK Advances New Malaria Drug With Completed First-in-Human Study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/GSKH/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":70.38,"timestamp":1789753707324,"preClose":71.7846,"halted":0,"volume":408,"delay":0,"changeRate":-0.019566870888742184,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Trading","change":-1.4046,"latestTime":"09-18 13:54:18 EDT","open":70.46,"high":70.56,"low":70.38,"amount":28744.122239999997,"amplitude":0.002508,"askPrice":70.5,"askSize":100,"bidPrice":70.42,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":71.7846,"nav":70.29546,"aum":703024.89546,"dividendRate":0.029477,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":70.6364,"preClose":71.7846,"latestTime":"16:10 EDT","volume":6,"amount":430.7076,"timestamp":1789675804131,"change":-1.1482,"changeRate":-0.015995,"amplitude":0},"volumeRatio":1.981693,"impliedVol":0.1437,"impliedVolPercentile":0.2119},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.981693,"shares":10001,"dividePrice":2.0746,"high":70.56,"amplitude":0.002508,"preClose":71.7846,"low":70.38,"week52Low":56.03,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":70.38,"eps":0,"divideRate":0.029477,"volume":408,"delay":0,"ttmEps":0,"open":70.46,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":66.9705,"twentyDayClose":71.6836,"sixtyDayClose":72.6862},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651428983","title":"GSK executives boost holdings via dividend-funded ADS purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=2651428983","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651428983?lang=en_us&edition=fundamental","pubTime":"2026-07-16 22:32","pubTimestamp":1784212352,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has disclosed a series of transactions in which several senior executives and non-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-boost-holdings-via-dividend-funded-ads-purchases?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-boost-holdings-via-dividend-funded-ads-purchases?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VIG","GSK","BK4588","BK4532","GSKH","LU1829250122.USD","GSK.UK","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651467645","title":"GSK’s New Phase 3 Ovarian Cancer Trial Puts Mo-Rez in the First-Line Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2651467645","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651467645?lang=en_us&edition=fundamental","pubTime":"2026-07-16 00:31","pubTimestamp":1784133105,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is launching a phase 3 trial called BEHOLD-Ovaria...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-phase-3-ovarian-cancer-trial-puts-mo-rez-in-the-first-line-spotlight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-phase-3-ovarian-cancer-trial-puts-mo-rez-in-the-first-line-spotlight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","GSK","BK4588","BK4585","BK4007","BK4532","LU1829250122.USD","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651846405","title":"Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651846405","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651846405?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:36","pubTimestamp":1784126191,"startTime":"0","endTime":"0","summary":"Laughing Water Capital’s recent decision to add AnaptysBio (ANAB) has drawn attention because it hinges on two factors: royalty income from the cancer drug Jemperli and an imminent commercial trial with partner GSK.\nSee our latest analysis for AnaptysBio.\nDespite the recent legal spotlight, AnaptysBio’s share price has been volatile, with a 1-day share price return down 10.46% and a 7-day share price return down 7.15%. However, a year-to-date share price return of 39.07% sits alongside a very...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anab/anaptysbio/news/is-anaptysbio-anab-undervalued-following-its-jemperli-royalt","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anab/anaptysbio/news/is-anaptysbio-anab-undervalued-following-its-jemperli-royalt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GSK","GSK.UK","ANAB","BK4139","BK4007","GSKH","LU1829250122.USD","FFTY","BK4532","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651690154","title":"GSK Completes $10.6 Billion Acquisition of Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2651690154","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651690154?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:16","pubTimestamp":1784124997,"startTime":"0","endTime":"0","summary":"GSK  said Wednesday it has completed the acquisition of Nuvalent , a Boston-based clinical-stage biopharmaceutical company, in a transaction with an aggregate equity value of about $10.6 billion.The transaction, which represents a net investment of about $9.4 billion after accounting for acquired cash, was finalized through a tender offer for all outstanding Nuvalent shares.The deal adds three lung cancer assets to GSK's oncology portfolio, according to a statement.Price: 51.55, Change: +0.30, Percent Change: +0.58","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NUVL","BK4539","BK4532","GSK","BK4007","GSKH","BK4585","BK4139","GSK.UK","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651468729","title":"iX Biopharma Warrants See Strong Insider Take-Up, Funding U.S. Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2651468729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651468729?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:08","pubTimestamp":1784117284,"startTime":"0","endTime":"0","summary":"The latest update is out from iX Biopharma Ltd. ( ($SG:42C) ). Singapore-based iX Biopharma Ltd. operates in the biopharmaceutical industry, focusi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ix-biopharma-warrants-see-strong-insider-take-up-funding-u-s-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ix-biopharma-warrants-see-strong-insider-take-up-funding-u-s-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4209","GSKH","SG","RSPH","MEDI","SURI","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651110571","title":"GSK Executives Acquire Shares Under Routine Reward Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651110571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651110571?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:32","pubTimestamp":1783953145,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has disclosed multiple small share acquisitions by senior executives under the company’s ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-routine-reward-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-routine-reward-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","BK4588","BK4585","GSK.UK","BK4007","GSK","LU1829250122.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651511137","title":"UBS Remains a Hold on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651511137","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651511137?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:16","pubTimestamp":1783944989,"startTime":"0","endTime":"0","summary":"UBS analyst Matthew Weston maintained a Hold rating on GlaxoSmithKline today and set a price target of £19.40. According to TipRanks, Weston is a 4...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU1829250122.USD","BK4585","BK4588","BK4532","GSK","GSKH","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651954591","title":"GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2651954591","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651954591?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:09","pubTimestamp":1783922982,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has reported positive interim phase II AZUR-1 data for its PD‑1 inhibitor Jemperli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-jemperli-trial-points-to-chemofree-future-for-subset-of-rectal-cancer-patients?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-jemperli-trial-points-to-chemofree-future-for-subset-of-rectal-cancer-patients?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSKH","PCOM","BK4588","BK4007","GSK.UK","LU1829250122.USD","GSK","BK4122","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156997423","title":"Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS","url":"https://stock-news.laohu8.com/highlight/detail?id=1156997423","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156997423?lang=en_us&edition=fundamental","pubTime":"2026-07-13 10:10","pubTimestamp":1783908642,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) shares rose more than 7% in early trading. At the time of writing, the stock is up 6.21% to HK$45.48, with a turnover of HK$332 million. On July 13th, according to a post on...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","AGIX","IE00BVYPNQ40.USD","SBIO","LFSC","BK1191","00867","VTHR","QTOC","IBB","SG9999004220.SGD","BBP","IE00BVYPNP33.GBP","CHAT","SG9999015945.SGD","SG9999015952.SGD","GSKH","BK1593","GDOC","IE00BYV24P56.USD","LU2488822045.USD","SG9999015978.USD","IE00BMCWC346.EUR","ARTY","IE00BGHQDM52.EUR","WRND","SG9999015986.USD","BK4585","PBE","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650139214","title":"Guggenheim Remains a Hold on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650139214","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650139214?lang=en_us&edition=fundamental","pubTime":"2026-07-10 23:45","pubTimestamp":1783698318,"startTime":"0","endTime":"0","summary":"Guggenheim analyst maintained a Hold rating on GlaxoSmithKline yesterday. The company’s shares closed today at p1,959.50. In addition to Guggenheim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GSK","BK4532","BK4588","GSK.UK","GSKH","LU1829250122.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650182181","title":"GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2650182181","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650182181?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:10","pubTimestamp":1783681857,"startTime":"0","endTime":"0","summary":"GSK (GSK) plc licensor Hansoh Pharmaceutical Group announced that ARTEMIS-008, its pivotal phase III trial evaluating risvutatug rezetecan, or Ris-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-says-hansoh-pharma-announces-positive-phase-3-results-for-ris-rez-in-china-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-says-hansoh-pharma-announces-positive-phase-3-results-for-ris-rez-in-china-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4588","GSK","GSK.UK","LU1829250122.USD","GSKH","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121894437","title":"Revenue Revision at Frontier Biotech Highlights Channel Pressures as Operating Losses Widen","url":"https://stock-news.laohu8.com/highlight/detail?id=1121894437","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121894437?lang=en_us&edition=fundamental","pubTime":"2026-07-10 14:21","pubTimestamp":1783664489,"startTime":"0","endTime":"0","summary":"Frontier Biotech has responded to the Shanghai Stock Exchange's 2025 annual report inquiry letter, providing clarifications on issues including revenue recognition adjustments, distributor inventory,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","GSK.UK","SPHQ","BK4007","BK4585","GSKH","LU1829250122.USD","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650978583","title":"GSK US President Acquires Notional ADS Under Executive Savings Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2650978583","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650978583?lang=en_us&edition=fundamental","pubTime":"2026-07-09 22:32","pubTimestamp":1783607547,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK disclosed that Maya Martinez-Davis, President of US operations and a person discharging m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-acquires-notional-ads-under-executive-savings-plan-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-acquires-notional-ads-under-executive-savings-plan-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4007","GSK.UK","GSKH","BK4585","LU1829250122.USD","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650940152","title":"GSK Adds Philips CEO Roy Jakobs to Board as Independent Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2650940152","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650940152?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:02","pubTimestamp":1783587750,"startTime":"0","endTime":"0","summary":"The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has appointed Roy Jakobs, the current chief executive of health technology g...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-adds-philips-ceo-roy-jakobs-to-board-as-independent-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-adds-philips-ceo-roy-jakobs-to-board-as-independent-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EKG","GSK.UK","GSK","BK4585","BK4007","BK4532","BK4588","GSKH","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115056703","title":"SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE","url":"https://stock-news.laohu8.com/highlight/detail?id=1115056703","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115056703?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:21","pubTimestamp":1783563660,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) climbed more than 5% during the morning session. At the time of writing, the stock was up 5.39% to HK$5.08, with a turnover of HK$239 million. Expanding a Strategic...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","HK0000165453.HKD","BK4532","BK1515","GSKH","BK4585","BK4588","GSK","GSK.UK","IE00BZ08YR35.GBP","LU1829250122.USD","BK1589","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK4007","01177","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650291696","title":"Alector Ends GSK Collaboration, Retires Hercules Capital Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2650291696","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650291696?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:32","pubTimestamp":1783542774,"startTime":"0","endTime":"0","summary":"Alector ( ($ALEC) ) has provided an announcement. On October 21, 2025, Alector reported that its Phase 3 INFRONT-3 trial of latozinemab in frontote...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alector-ends-gsk-collaboration-retires-hercules-capital-debt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alector-ends-gsk-collaboration-retires-hercules-capital-debt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEX","PBDC","BK4532","GSKH","HTGC","BK4588","BK4007","GSK.UK","LU1829250122.USD","GSK","BK4135","FXED","BK4585","BIZD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650861990","title":"GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2650861990","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650861990?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:32","pubTimestamp":1783528353,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK steps up its respiratory vaccine push with a new study, NCT07628049...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-rsv-hmpv-vaccine-trial-adds-momentum-to-its-respiratory-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-rsv-hmpv-vaccine-trial-adds-momentum-to-its-respiratory-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSK","BK4007","BK4585","GSK.UK","LU1829250122.USD","BK4588","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650997074","title":"GSK Targets Pediatric Vaccine Growth With New Phase 3 Trial Against Merck’s ProQuad","url":"https://stock-news.laohu8.com/highlight/detail?id=2650997074","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650997074?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:32","pubTimestamp":1783528329,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running a Phase 3 study called “A Phase 3a, Observer...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-targets-pediatric-vaccine-growth-with-new-phase-3-trial-against-mercks-proquad?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-targets-pediatric-vaccine-growth-with-new-phase-3-trial-against-mercks-proquad?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0203347892.USD","SGXZ57979304.SGD","LU1923622614.USD","LU0266013472.USD","LU1066051811.HKD","LU0289739699.SGD","BMED","SG9999001440.SGD","LU0859254822.USD","LU0980610538.SGD","LU0208291251.USD","LU0477156953.USD","LU1162221912.USD","LU0070302665.USD","IE00BFTCPJ56.SGD","LU2357627491.SGD","LU0058720904.USD","LU2361044949.HKD","LU1037948897.HKD","LU2361045086.USD","GSK.UK","JDOC","LU2491049909.HKD","SG9999001176.SGD","LU0985320562.USD","LU1934455277.USD","LU2360032135.SGD","LU1989772923.USD","LU2125909247.SGD","LU0211331839.USD","MRK","LU2433249047.HKD","BK4533","LU1934455863.HKD","LU0098860793.USD","LU1035773651.USD","FTXH","BK4007","IE00BLSP4452.SGD","LU2125154778.USD","LU1941712348.USD","IE0009355771.USD","LU0965509283.SGD","LU0432979614.USD","LU0130102774.USD","LU2125909593.SGD","SG9999014567.USD","SG9999014559.SGD","LU2089984988.USD","SG9999015341.SGD","LU1585245621.USD","IYH","LU1037948541.HKD","LU1974910355.USD","SG9999015358.SGD","LU1291159041.SGD","IE00BBT3K403.USD","LU2461242641.AUD","IHE","IE00B1BXHZ80.USD","IE000M9KFDE8.USD","VHT","LU1023059063.AUD","LU0320765646.SGD","LU1934455194.USD","LU1941712264.USD","PAWZ","GSKH","LU1201861249.SGD","LU0238689110.USD","LU2491050154.USD","LU0106261372.USD","SG9999001176.USD","LU0006306889.USD","XLV","RXL","SG9999002224.SGD","BK4559","IE0002141913.USD","IE00B4R5TH58.HKD","LU1571399168.USD","LU0265550946.USD","LU2491050071.SGD","LU1093756325.SGD","LU1069347547.HKD","LU2112291526.USD","IE00BJT1NW94.SGD","LU1066053197.SGD","IE00BN8TJ469.HKD","IXJ","FHLC","BK4532","LU1829250122.USD","LU2023250843.SGD","LU0203345920.USD","LU1929549753.HKD","LU1093756168.USD","GSK","LU0942090050.USD","BK4534","LU1699723380.USD","LU1983299246.USD","LU1057294990.SGD","LU0234572021.USD","LU0965509010.AUD","BK4516","IE00BLSP4239.USD","LU0868494617.USD","LU1917777945.USD","LU1066051498.USD","LU0265550359.USD","LU0122379950.USD","LU0965509101.SGD","SG9999013999.USD","LU0320765489.SGD","LU1116320737.USD","LU0868494708.USD","LU1066051225.USD","LU2125154935.USD","HRTS","BK4550","BK4588","LU2023250504.SGD","LU2468319806.SGD","LU0861579265.USD","IE00B2B36J28.USD","LU1116320901.HKD","SG9999002232.USD","LU0965508806.USD","SG9999014542.SGD","GDOC","LU0648001328.SGD","BK4585","LU1430594728.SGD","LU0130517989.USD","IE00BSNM7G36.USD","SG9999014575.USD","IE00BJJMRZ35.SGD","LU1989771016.USD","LU2324357040.USD","LU2106854487.HKD","LU1061106388.HKD","LU1989772840.SGD","LU2361044865.SGD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650499086","title":"GSK Advances Novel Malaria Drug Into Phase 2A, Signaling Long-Term Global Health Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2650499086","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650499086?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:31","pubTimestamp":1783528313,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is launching a Phase 2A study called “A Phase 2A Study ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-novel-malaria-drug-into-phase-2a-signaling-long-term-global-health-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-novel-malaria-drug-into-phase-2a-signaling-long-term-global-health-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSKH","LU1829250122.USD","BK4588","GSK.UK","BK4007","GSK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650990883","title":"GSK Advances New Malaria Drug With Completed First-in-Human Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2650990883","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650990883?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:30","pubTimestamp":1783528209,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The study, officially titled A Phase 1, Randomised, Double Blind Placeb...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-malaria-drug-with-completed-first-in-human-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-malaria-drug-with-completed-first-in-human-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4532","BK4007","LU1829250122.USD","GSK","BK4588","GSKH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}